Prophylactic or therapeutic doses of heparins for COVID-19 infection? A retrospective study.

Francesco BolzettaMonica MaselliMarino FormilanFlavio BusoneraPaolo AlbaneseFederica ChiaromanniAntonietta RomanoNicola Veronese

Published in: Aging clinical and experimental research (2020)

Our paper indicates that in older people affected by COVID-19 there is no justification for using therapeutic doses instead of prophylactic ones, having a similar impact on mortality risk.

Keyphrases

coronavirus disease
sars cov